Castillo, M.E. et al. Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study. Journal of Steroid Biochemistry and Molecular Biology. 203 (2020) 105751. [Vitamin D – effective treatment for COVID]
Koetsier, J. The 100 Safest Countries For COVID-19. Forbes. 9/3/20.
Bourouiba L. Turbulent gas clouds and respiratory pathogen emissions: potential implications for reducing transmission of COVID-19. JAMA2020. doi:10.1001/jama.2020.4756.
How Cannabis-Based Therapeutics Could Help Fight COVID Inflammation. Medscape. 11/6/20. Cannabis & Cancer:
Society of Cannabis Clinicians O’Shaughnessy’s, The Journal of Cannabis in Clinical Practice, email: email@example.com; write to: P. O. Box 490, Alameda CA 94501.
Smoke Signals, The Book: A Social History of Marijuana—Medical, Recreational and Scientific, Martin Lee, Director of Project CBD, Simon & Schuster, 2013.
Bachhuber MA, et al. Medical cannabis laws and opioid analgesic overdose mortality in the United States. 1999-2010. JAMA Int’l Med. 2014:174(10):1668-73.
Carroll, C.B. et al. (2004). Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study. Neurology, 63(7), 1245-1250.
Eubanks, Lisa M., et al. “A molecular link between the active component of marijuana and Alzheimer’s disease pathology.” Mol. Pharm 3.6 (2006): 773-777.
Guzmán M. Cannabinoids: Potential anticancer agents. Nat Rev Cancer. 2003; 3:745-755.
Hurd, Yasmin L. “Cannabidiol: Swinging the marijuana pendulum from ‘weed’ to medication to treat the opioid epidemic.” Trends in Neurosciences 40.3 (2017): 124-127.
Lynch, M. E. and Mark A. Ware. “Cannabinoids for the treatment of chronic non-cancer pain; an updated systematic review of randomized controlled trials.” Journal of neuroimmune pharmacology 10.2 (2015): 293-301.
Naftali, Timna, et al. “Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo-controlled study.” Clinical Gastroenterology and Hepatology 11.10 (2013): 1276- 1280.
National Institute of Drug Abuse: is marijuana a gateway drug?
Porter, B. E. & Jacobson, C. (2013). Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy Behav. 29, 574-7.
Reiman, Amanda. “Cannabis as a substitute for alcohol and other drugs.” Harm Reduction Journal 6.1 (2009):35.
Russo EB. History of cannabis and its preparations in saga, science and sobriquet. Chemistry & Biodiversity. 2007:4(8):2624-48.
Whitaker, Robert. Anatomy of an Epidemic. History of how the big pharma took over health care through the 20th century. 2010.
Wall, Melanie M., et al. “Prevalence of marijuana use does not differentially increase among youth after states pass medical marijuana laws: Commentary on and reanalysis of US National Survey on Drug Use in Households data 2002-2011.” International Journal of Drug Policy 29 (2016): 9-13.